Global mRNA Vaccines & Therapeutics Market 2020 by Manufacturers, Type and Application, Forecast to 2025

  • receipt Report ID : 96220
  • calendar_today Published On: Aug, 2020
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

Market Overview

The mRNA Vaccines & Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global mRNA Vaccines & Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 8.3%% in the forecast period of 2020 to 2025 and will expected to reach USD 1666.7 million by 2025, from USD 1210.4 million in 2019.

Market segmentation

mRNA Vaccines & Therapeutics market is split by Type and Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Breakdown by Type, mRNA Vaccines & Therapeutics market has been segmented into Standardization Of Cancer Treatment MRNA Vaccine, Individualized Cancer Treatment MRNA Vaccine, Infectious Disease Treatment MRNA Vaccine, Infection Prevention MRNA Vaccine, etc.

Breakdown by Application, mRNA Vaccines & Therapeutics has been segmented into Infectious Disease, Cancer, Other, etc.

Regions and Countries Level Analysis

Regional analysis is another highly comprehensive part of the research and analysis study of the global mRNA Vaccines & Therapeutics market presented in the report. This section sheds light on the sales growth of different regional and country-level mRNA Vaccines & Therapeutics markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global mRNA Vaccines & Therapeutics market.

For China, this report analyses the China market by players, Type and Application, for the period 2015-2025.

Competitive Landscape and mRNA Vaccines & Therapeutics Market Share Analysis

mRNA Vaccines & Therapeutics competitive landscape provides details by vendors, including company overview, company total revenue, market potential, global presence, mRNA Vaccines & Therapeutics sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the mRNA Vaccines & Therapeutics sales, revenue and market share for each player covered in this report.

The major players covered in mRNA Vaccines & Therapeutics are: Moderna Therapeutics, eTheRNA, BioNTech, CureVac, In-Cell-Art, Translate Bio, Tiba Biotechnology, Argos Therapeutics, Sangamo Therapeutics, Ethris, etc. Among other players domestic and global, mRNA Vaccines & Therapeutics market share data is available for global, North America, Europe, Asia, Middle East and Africa and South America separately. Our analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The key market players for global mRNA Vaccines & Therapeutics market are listed below:

Moderna Therapeutics

eTheRNA

BioNTech

CureVac

In-Cell-Art

Translate Bio

Tiba Biotechnology

Argos Therapeutics

Sangamo Therapeutics

Ethris

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)

South America (Brazil, Argentina)

Middle East & Africa (Saudi Arabia, UAE, Egypt and South Africa)

Market segment by Type, covers:

Standardization Of Cancer Treatment MRNA Vaccine

Individualized Cancer Treatment MRNA Vaccine

Infectious Disease Treatment MRNA Vaccine

Infection Prevention MRNA Vaccine

Market segment by Application, can be divided into

Infectious Disease

Cancer

Other

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 mRNA Vaccines & Therapeutics Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global mRNA Vaccines & Therapeutics Revenue by Type: 2015 VS 2019 VS 2025

1.2.2 Standardization Of Cancer Treatment MRNA Vaccine

1.2.3 Individualized Cancer Treatment MRNA Vaccine

1.2.4 Infectious Disease Treatment MRNA Vaccine

1.2.5 Infection Prevention MRNA Vaccine

1.3 Market Analysis by Application

1.3.1 Overview: Global mRNA Vaccines & Therapeutics Revenue by Application: 2015 VS 2019 VS 2025

1.3.2 Infectious Disease

1.3.3 Cancer

1.3.4 Other

1.4 Global mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

1.4.1 Global mRNA Vaccines & Therapeutics Revenue and Forecast (2015-2025)

1.4.2 Global mRNA Vaccines & Therapeutics Sales and Forecast (2015-2025)

1.5 Global mRNA Vaccines & Therapeutics Market Size Overview by Geography (2015-2020)

2 Manufacturers Profiles

2.1 Moderna Therapeutics

2.1.1 Moderna Therapeutics Details

2.1.2 Moderna Therapeutics Major Business

2.1.3 Moderna Therapeutics SWOT Analysis

2.1.4 Moderna Therapeutics Product and Services

2.1.5 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.2 eTheRNA

2.2.1 eTheRNA Details

2.2.2 eTheRNA Major Business

2.2.3 eTheRNA SWOT Analysis

2.2.4 eTheRNA Product and Services

2.2.5 eTheRNA mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.3 BioNTech

2.3.1 BioNTech Details

2.3.2 BioNTech Major Business

2.3.3 BioNTech SWOT Analysis

2.3.4 BioNTech Product and Services

2.3.5 BioNTech mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.4 CureVac

2.4.1 CureVac Details

2.4.2 CureVac Major Business

2.4.3 CureVac SWOT Analysis

2.4.4 CureVac Product and Services

2.4.5 CureVac mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.5 In-Cell-Art

2.5.1 In-Cell-Art Details

2.5.2 In-Cell-Art Major Business

2.5.3 In-Cell-Art SWOT Analysis

2.5.4 In-Cell-Art Product and Services

2.5.5 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.6 Translate Bio

2.6.1 Translate Bio Details

2.6.2 Translate Bio Major Business

2.6.3 Translate Bio Product and Services

2.6.4 Translate Bio mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.7 Tiba Biotechnology

2.7.1 Tiba Biotechnology Details

2.7.2 Tiba Biotechnology Major Business

2.7.3 Tiba Biotechnology Product and Services

2.7.4 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.8 Argos Therapeutics

2.8.1 Argos Therapeutics Details

2.8.2 Argos Therapeutics Major Business

2.8.3 Argos Therapeutics Product and Services

2.8.4 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.9 Sangamo Therapeutics

2.9.1 Sangamo Therapeutics Details

2.9.2 Sangamo Therapeutics Major Business

2.9.3 Sangamo Therapeutics Product and Services

2.9.4 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

2.10 Ethris

2.10.1 Ethris Details

2.10.2 Ethris Major Business

2.10.3 Ethris Product and Services

2.10.4 Ethris mRNA Vaccines & Therapeutics Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)

3 Global mRNA Vaccines & Therapeutics Market, Company Landscape

3.1 Company Market Share Analysis: Global

3.1.1 Global mRNA Vaccines & Therapeutics Sales and Market Share by Manufacturer (2018-2019)

3.1.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Manufacturer (2018-2019)

3.2 Company Market Share Analysis: China

3.2.1 Key Players mRNA Vaccines & Therapeutics Sales in China (2018-2019)

3.2.2 China mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer (2018-2019)

3.3 Market Concentration Rate

3.3.1 Top 3 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2019

3.3.2 Top 6 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2019

4 Market Size by Geography

4.1 Global mRNA Vaccines & Therapeutics Market Size by Geography (2015-2020)

4.1.1 Global mRNA Vaccines & Therapeutics Sales by Geography (2015-2020)

4.1.2 Global mRNA Vaccines & Therapeutics Revenue by Regions (2015-2020)

4.2 Global mRNA Vaccines & Therapeutics Market Size and Forecast by Regions (2020-2025)

4.2.1 Global mRNA Vaccines & Therapeutics Sales and Forecast by Regions (2020-2025)

4.2.2 Global mRNA Vaccines & Therapeutics Revenue and Forecast by Regions (2020-2025)

4.3 North America mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

4.4 Europe mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

4.5 Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

4.6 South America mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

4.7 Middle East and Africa mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

5 North America by Country

5.1 North America mRNA Vaccines & Therapeutics Market Size by Country (2015-2020)

5.1.1 North America mRNA Vaccines & Therapeutics Sales and Market Share by Country (2015-2020)

5.1.2 North America mRNA Vaccines & Therapeutics Revenue and Market Share by Country (2015-2020)

5.2 North America mRNA Vaccines & Therapeutics Market Size and Forecast by Country (2020-2025)

5.2.1 North America mRNA Vaccines & Therapeutics Sales and Forecast by Country (2020-2025)

5.2.2 North America mRNA Vaccines & Therapeutics Revenue and Forecast by Country (2020-2025)

5.3 United States mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

5.4 Canada mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

5.5 Mexico mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

6 Europe by Country

6.1 Europe mRNA Vaccines & Therapeutics Market Size by Country (2015-2020)

6.1.1 Europe mRNA Vaccines & Therapeutics Sales by Country (2015-2020)

6.1.2 Europe mRNA Vaccines & Therapeutics Revenue by Country (2015-2020)

6.2 Europe mRNA Vaccines & Therapeutics Market Size and Forecast by Country (2020-2025)

6.2.1 Europe mRNA Vaccines & Therapeutics Sales and Forecast by Country (2020-2025)

6.2.2 Europe mRNA Vaccines & Therapeutics Revenue and Forecast by Country (2020-2025)

6.3 Germany mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

6.4 United Kingdom mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

6.5 France mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

6.6 Russia mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

6.7 Italy mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

7 Asia-Pacific by Regions

7.1 Asia-Pacific mRNA Vaccines & Therapeutics Market Size by Region (2015-2020)

7.1.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales by Region (2015-2020)

7.1.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Region (2015-2020)

7.2 Asia-Pacific mRNA Vaccines & Therapeutics Market Size and Forecast by Region (2020-2025)

7.2.1 Asia-Pacific mRNA Vaccines & Therapeutics Sales and Forecast by Region (2020-2025)

7.2.2 Asia-Pacific mRNA Vaccines & Therapeutics Revenue and Forecast by Region (2020-2025)

7.3 China mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

7.4 Japan mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

7.5 Korea mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

7.6 India mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

7.7 Southeast Asia mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

7.8 Australia mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

8 South America by Country

8.1 South America mRNA Vaccines & Therapeutics Market Size by Country (2015-2020)

8.1.1 South America mRNA Vaccines & Therapeutics Sales by Country (2015-2020)

8.1.2 South America mRNA Vaccines & Therapeutics Revenue by Country (2015-2020)

8.2 South America mRNA Vaccines & Therapeutics Market Size and Forecast by Country (2020-2025)

8.2.1 South America mRNA Vaccines & Therapeutics Sales and Forecast by Country (2020-2025)

8.2.2 South America mRNA Vaccines & Therapeutics Revenue and Forecast by Country (2020-2025)

8.3 Brazil mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

8.4 Argentina mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

9 Middle East & Africa by Countries

9.1 Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Country (2015-2020)

9.1.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2015-2020)

9.1.2 Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2015-2020)

9.2 Middle East & Africa mRNA Vaccines & Therapeutics Market Size and Forecast by Country (2020-2025)

9.2.1 Middle East & Africa mRNA Vaccines & Therapeutics Sales and Forecast by Country (2020-2025)

9.2.2 Middle East & Africa mRNA Vaccines & Therapeutics Revenue and Forecast by Country (2020-2025)

9.3 Saudi Arabia mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

9.4 Turkey mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

9.5 Egypt mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

9.6 South Africa mRNA Vaccines & Therapeutics Market Size and Forecast (2015-2025)

10 Market Segment by Type

10.1 Global mRNA Vaccines & Therapeutics Market Size by Type (2015-2020)

10.1.1 Global mRNA Vaccines & Therapeutics Sales by Type (2015-2020)

10.1.2 Global mRNA Vaccines & Therapeutics Revenue by Type (2015-2020)

10.1.3 Global mRNA Vaccines & Therapeutics Price by Type (2015-2020)

10.2 Global mRNA Vaccines & Therapeutics Market Size and Forecast by Type (2020-2025)

10.2.1 Global mRNA Vaccines & Therapeutics Sales and Forecast by Type (2020-2025)

10.2.2 Global mRNA Vaccines & Therapeutics Revenue and Forecast by Type (2020-2025)

10.2.3 Global mRNA Vaccines & Therapeutics Price and Forecast by Type (2020-2025)

10.3 China mRNA Vaccines & Therapeutics Market Size and Forecast by Type (2015-2025)

10.3.1 China mRNA Vaccines & Therapeutics Market Size by Type (2015-2020)

10.3.2 China mRNA Vaccines & Therapeutics Market Size and Forecast by Type (2020-2025)

11 Market Segment by Application

11.1 Global mRNA Vaccines & Therapeutics Market Size by Application (2015-2020)

11.1.1 Global mRNA Vaccines & Therapeutics Sales by Application (2015-2020)

11.1.2 Global mRNA Vaccines & Therapeutics Revenue by Application (2015-2020)

11.1.3 Global mRNA Vaccines & Therapeutics Price by Application (2015-2020)

11.2 Global mRNA Vaccines & Therapeutics Market Size and Forecast by Application (2020-2025)

11.2.1 Global mRNA Vaccines & Therapeutics Sales and Forecast by Application (2020-2025)

11.2.2 Global mRNA Vaccines & Therapeutics Revenue and Forecast by Application (2020-2025)

11.2.3 Global mRNA Vaccines & Therapeutics Price and Forecast by Application (2020-2025)

11.3 China mRNA Vaccines & Therapeutics Market Size and Forecast by Application (2015-2025)

11.3.1 China mRNA Vaccines & Therapeutics Market Size by Application (2015-2020)

11.3.2 China mRNA Vaccines & Therapeutics Market Size and Forecast by Application (2020-2025)

12 Sales Channel, Distributors, Costumers, and Market Dynamics

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Distributors, Traders and Dealers

12.4.1 Market Opportunities

12.4.2 Market Risk

12.4.3 Market Driving Force

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

14.3 Disclaimer

14.4 About US

List of Tables

Table 1. Global mRNA Vaccines & Therapeutics Revenue (USD Million) by Type: 2015 VS 2019 VS 2025

Table 2. Breakdown of mRNA Vaccines & Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 3. Global mRNA Vaccines & Therapeutics Revenue (USD Million) by Application: 2015 VS 2019 VS 2025

Table 4. Global mRNA Vaccines & Therapeutics Market Size Overview by Geography (2015-2020) (USD Million)

Table 5. Global mRNA Vaccines & Therapeutics Market Size and Growth Estimation in Various Scenarios in 2020

Table 6. Moderna Therapeutics Basic Information, Manufacturing Base and Competitors

Table 7. Moderna Therapeutics mRNA Vaccines & Therapeutics Major Business

Table 8. Moderna Therapeutics mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)

Table 9. Moderna Therapeutics SWOT Analysis

Table 10. Moderna Therapeutics mRNA Vaccines & Therapeutics Product and Services

Table 11. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 12. eTheRNA Basic Information, Manufacturing Base and Competitors

Table 13. eTheRNA mRNA Vaccines & Therapeutics Major Business

Table 14. eTheRNA mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)

Table 15. eTheRNA SWOT Analysis

Table 16. eTheRNA mRNA Vaccines & Therapeutics Product and Services

Table 17. eTheRNA mRNA Vaccines & Therapeutics Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 18. BioNTech Basic Information, Manufacturing Base and Competitors

Table 19. BioNTech mRNA Vaccines & Therapeutics Major Business

Table 20. BioNTech mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)

Table 21. BioNTech SWOT Analysis

Table 22. BioNTech mRNA Vaccines & Therapeutics Product and Services

Table 23. BioNTech mRNA Vaccines & Therapeutics Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 24. CureVac Basic Information, Manufacturing Base and Competitors

Table 25. CureVac mRNA Vaccines & Therapeutics Major Business

Table 26. CureVac mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)

Table 27. CureVac SWOT Analysis

Table 28. CureVac mRNA Vaccines & Therapeutics Product and Services

Table 29. CureVac mRNA Vaccines & Therapeutics Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 30. In-Cell-Art Basic Information, Manufacturing Base and Competitors

Table 31. In-Cell-Art mRNA Vaccines & Therapeutics Major Business

Table 32. In-Cell-Art mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)

Table 33. In-Cell-Art SWOT Analysis

Table 34. In-Cell-Art mRNA Vaccines & Therapeutics Product and Services

Table 35. In-Cell-Art mRNA Vaccines & Therapeutics Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 36. Translate Bio Basic Information, Manufacturing Base and Competitors

Table 37. Translate Bio mRNA Vaccines & Therapeutics Major Business

Table 38. Translate Bio mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)

Table 39. Translate Bio SWOT Analysis

Table 40. Translate Bio mRNA Vaccines & Therapeutics Product and Services

Table 41. Translate Bio mRNA Vaccines & Therapeutics Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 42. Tiba Biotechnology Basic Information, Manufacturing Base and Competitors

Table 43. Tiba Biotechnology mRNA Vaccines & Therapeutics Major Business

Table 44. Tiba Biotechnology mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)

Table 45. Tiba Biotechnology SWOT Analysis

Table 46. Tiba Biotechnology mRNA Vaccines & Therapeutics Product and Services

Table 47. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 48. Argos Therapeutics Basic Information, Manufacturing Base and Competitors

Table 49. Argos Therapeutics mRNA Vaccines & Therapeutics Major Business

Table 50. Argos Therapeutics mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)

Table 51. Argos Therapeutics SWOT Analysis

Table 52. Argos Therapeutics mRNA Vaccines & Therapeutics Product and Services

Table 53. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 54. Sangamo Therapeutics Basic Information, Manufacturing Base and Competitors

Table 55. Sangamo Therapeutics mRNA Vaccines & Therapeutics Major Business

Table 56. Sangamo Therapeutics mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)

Table 57. Sangamo Therapeutics SWOT Analysis

Table 58. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product and Services

Table 59. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 60. Ethris Basic Information, Manufacturing Base and Competitors

Table 61. Ethris mRNA Vaccines & Therapeutics Major Business

Table 62. Ethris mRNA Vaccines & Therapeutics Total Revenue (USD Million) (2018-2019)

Table 63. Ethris SWOT Analysis

Table 64. Ethris mRNA Vaccines & Therapeutics Product and Services

Table 65. Ethris mRNA Vaccines & Therapeutics Sales (K Units), Price (USD/Unit), Revenue, Gross Margin and Market Share (2018-2019)

Table 66. Global mRNA Vaccines & Therapeutics Sales by Manufacturer (2018-2019) (K Units)

Table 67. Global mRNA Vaccines & Therapeutics Revenue by Manufacturer (2018-2019) (USD Million)

Table 68. Key Players mRNA Vaccines & Therapeutics Sales in China (2018-2019) (K Units)

Table 69. Key Players mRNA Vaccines & Therapeutics Sales Market Share in China (2018-2019)

Table 70. Key Players Revenue of mRNA Vaccines & Therapeutics in China (2018-2019) (USD Million)

Table 71. Global mRNA Vaccines & Therapeutics Sales by Regions (2015-2020) (K Units)

Table 72. Global mRNA Vaccines & Therapeutics Sales Market Share by Regions (2015-2020)

Table 73. Global mRNA Vaccines & Therapeutics Revenue by Regions (2015-2020) (USD Million)

Table 74. Global mRNA Vaccines & Therapeutics Sales and Forecast by Regions (2020-2025) (K Units)

Table 75. Global mRNA Vaccines & Therapeutics Sales Market Share by Regions (2020-2025)

Table 76. Global mRNA Vaccines & Therapeutics Revenue and Forecast by Regions (2020-2025) (USD Million)

Table 77. Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions (2020-2025) (USD Million)

Table 78. North America mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)

Table 79. North America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)

Table 80. North America mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (USD Million)

Table 81. North America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)

Table 82. North America mRNA Vaccines & Therapeutics Sales by Country (2020-2025) (K Units)

Table 83. North America mRNA Vaccines & Therapeutics Sales Market Share by Country (2020-2025)

Table 84. North America mRNA Vaccines & Therapeutics Revenue by Country (2020-2025) (USD Million)

Table 85. North America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2020-2025)

Table 86. Europe mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)

Table 87. Europe mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)

Table 88. Europe mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (USD Million)

Table 89. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)

Table 90. Europe mRNA Vaccines & Therapeutics Sales by Country (2020-2025) (K Units)

Table 91. Europe mRNA Vaccines & Therapeutics Sales Market Share by Country (2020-2025)

Table 92. Europe mRNA Vaccines & Therapeutics Revenue by Country (2020-2025) (USD Million)

Table 93. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country (2020-2025)

Table 94. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)

Table 95. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)

Table 96. Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (USD Million)

Table 97. Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)

Table 98. Asia-Pacific mRNA Vaccines & Therapeutics Sales by Country (2020-2025) (K Units)

Table 99. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Country (2020-2025)

Table 100. Asia-Pacific mRNA Vaccines & Therapeutics Revenue by Country (2020-2025) (USD Million)

Table 101. Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Country (2020-2025)

Table 102. South America mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)

Table 103. South America mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)

Table 104. South America mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (USD Million)

Table 105. South America mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)

Table 106. South America mRNA Vaccines & Therapeutics Sales by Country (2020-2025) (K Units)

Table 107. South America mRNA Vaccines & Therapeutics Sales Market Share by Country (2020-2025)

Table 108. South America mRNA Vaccines & Therapeutics Revenue by Country (2020-2025) (USD Million)

Table 109. South America mRNA Vaccines & Therapeutics Revenue Market Share by Country (2020-2025)

Table 110. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Countries (2015-2020) (K Units)

Table 111. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Countries (2015-2020)

Table 112. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Countries (2015-2020) (USD Million)

Table 113. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Countries (2015-2020)

Table 114. Middle East & Africa mRNA Vaccines & Therapeutics Sales by Country (2020-2025) (K Units)

Table 115. Middle East & Africa mRNA Vaccines & Therapeutics Sales Market Share by Country (2020-2025)

Table 116. Middle East & Africa mRNA Vaccines & Therapeutics Revenue by Country (2020-2025) (USD Million)

Table 117. Middle East & Africa mRNA Vaccines & Therapeutics Revenue Market Share by Country (2020-2025)

Table 118. China mRNA Vaccines & Therapeutics Sales by Type (2015-2020) (K Units)

Table 119. China mRNA Vaccines & Therapeutics Sales Market Share by Type (2015-2020)

Table 120. China mRNA Vaccines & Therapeutics Revenue by Type (2015-2020) (USD Million)

Table 121. China mRNA Vaccines & Therapeutics Revenue Market Share by Type (2015-2020)

Table 122. China mRNA Vaccines & Therapeutics Sales by Type (2020-2025) (K Units)

Table 123. China mRNA Vaccines & Therapeutics Sales Market Share by Type (2020-2025)

Table 124. China mRNA Vaccines & Therapeutics Revenue by Type (2020-2025) (USD Million)

Table 125. China mRNA Vaccines & Therapeutics Revenue Market Share by Type (2020-2025)

Table 126. Global mRNA Vaccines & Therapeutics Sales by Application (2015-2020) (K Units)

Table 127. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)

Table 128. Global mRNA Vaccines & Therapeutics Revenue by Application (2015-2020) (USD Million)

Table 129. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2015-2020)

Table 130. Global mRNA Vaccines & Therapeutics Price by Application (2015-2020) (USD/Unit)

Table 131. Global mRNA Vaccines & Therapeutics Sales by Application (2020-2025) (K Units)

Table 132. Global mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2025)

Table 133. Global mRNA Vaccines & Therapeutics Revenue by Application (2020-2025) (USD Million)

Table 134. Global mRNA Vaccines & Therapeutics Revenue Market Share by Application (2020-2025)

Table 135. Global mRNA Vaccines & Therapeutics Price by Application (2020-2025) (USD/Unit)

Table 136. China mRNA Vaccines & Therapeutics Sales by Application (2015-2020) (K Units)

Table 137. China mRNA Vaccines & Therapeutics Sales Market Share by Application (2015-2020)

Table 138. China mRNA Vaccines & Therapeutics Revenue by Application (2015-2020) (USD Million)

Table 139. China mRNA Vaccines & Therapeutics Revenue Market Share by Application (2015-2020)

Table 140. China mRNA Vaccines & Therapeutics Sales by Application (2020-2025) (K Units)

Table 141. China mRNA Vaccines & Therapeutics Sales Market Share by Application (2020-2025)

Table 142. China mRNA Vaccines & Therapeutics Revenue by Application (2020-2025) (USD Million)

Table 143. China mRNA Vaccines & Therapeutics Revenue Market Share by Application (2020-2025)

Table 144. Direct Channel Pros & Cons

Table 145. Indirect Channel Pros & Cons

Table 146. Distributors/Traders/ Dealers List

Table 147. Customers of mRNA Vaccines & Therapeutics

Table 148. Market Opportunities in Next Few Years

Table 149. Market Risks Analysis

Table 150. Market Drivers

List of Figures

Figure 1. mRNA Vaccines & Therapeutics Picture

Figure 2. Global mRNA Vaccines & Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 3. Standardization Of Cancer Treatment MRNA Vaccine Picture

Figure 4. Individualized Cancer Treatment MRNA Vaccine Picture

Figure 5. Infectious Disease Treatment MRNA Vaccine Picture

Figure 6. Infection Prevention MRNA Vaccine Picture

Figure 7. mRNA Vaccines & Therapeutics Sales Market Share by Application in 2019

Figure 8. Infectious Disease Picture

Figure 9. Cancer Picture

Figure 10. Other Picture

Figure 11. Global mRNA Vaccines & Therapeutics Market Status and Outlook (2015-2025) (USD Million)

Figure 12. Global mRNA Vaccines & Therapeutics Sales Growth Rate (2015-2025) (K Units)

Figure 13. Global mRNA Vaccines & Therapeutics Sales Market Share by Manufacturer in 2019

Figure 14. Global mRNA Vaccines & Therapeutics Revenue Market Share by Manufacturer in 2019

Figure 15. Key Players mRNA Vaccines & Therapeutics Revenue Market Share in China in 2019

Figure 16. Global Top 5 mRNA Vaccines & Therapeutics Manufacturer Market Share in 2019

Figure 17. Top 3 mRNA Vaccines & Therapeutics Players Market Share in China in 2019

Figure 18. Global mRNA Vaccines & Therapeutics Revenue Market Share by Regions in 2019

Figure 19. North America mRNA Vaccines & Therapeutics Sales YoY Growth (2015-2025) (K Units)

Figure 20. North America mRNA Vaccines & Therapeutics Revenue YoY Growth (2015-2025) (USD Million)

Figure 21. Europe mRNA Vaccines & Therapeutics Sales YoY Growth (2015-2020) (K Units)

Figure 22. Europe mRNA Vaccines & Therapeutics Revenue YoY Growth (2015-2020) (USD Million)

Figure 23. Asia-Pacific mRNA Vaccines & Therapeutics Sales YoY Growth (2015-2020) (K Units)

Figure 24. Asia-Pacific mRNA Vaccines & Therapeutics Revenue YoY Growth (2015-2020) (USD Million)

Figure 25. South America mRNA Vaccines & Therapeutics Sales YoY Growth (2015-2020) (K Units)

Figure 26. South America mRNA Vaccines & Therapeutics Revenue YoY Growth (2015-2020) (USD Million)

Figure 27. Middle East & Africa mRNA Vaccines & Therapeutics Sales YoY Growth (2015-2020) (K Units)

Figure 28. Middle East & Africa mRNA Vaccines & Therapeutics Revenue YoY Growth (2015-2020) (USD Million)

Figure 29. North America mRNA Vaccines & Therapeutics Sales Market Share by Country in 2019

Figure 30. North America mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2019

Figure 31. United States mRNA Vaccines & Therapeutics Market Size and Growth Rate (2015-2025) (USD Million)

Figure 32. Canada mRNA Vaccines & Therapeutics Market Size and Growth Rate (2015-2025) (USD Million)

Figure 33. Mexico mRNA Vaccines & Therapeutics Market Size and Growth Rate (2015-2020) (USD Million)

Figure 34. Europe mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2019

Figure 35. Germany mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 36. United Kingdom mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 37. France mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 38. Russia mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 39. Italy mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 40. Asia-Pacific mRNA Vaccines & Therapeutics Sales Market Share by Region 2018

Figure 41. Asia-Pacific mRNA Vaccines & Therapeutics Revenue Market Share by Region 2018

Figure 42. China mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 43. Japan mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 44. Korea mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 45. India mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 46. Southeast Asia mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 47. Australia mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 48. South America mRNA Vaccines & Therapeutics Sales Market Share by Country in 2019

Figure 49. South America mRNA Vaccines & Therapeutics Revenue Market Share by Country in 2019

Figure 50. Brazil mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 51. Argentina mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 52. Saudi Arabia mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 53. Turkey mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 54. Egypt mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 55. South Africa mRNA Vaccines & Therapeutics Market Size Growth Rate (2015-2025) (USD Million)

Figure 56. Global Revenue Market Share of mRNA Vaccines & Therapeutics by Type in 2019

Figure 57. Global Revenue Market Share of mRNA Vaccines & Therapeutics by Application in 2019

Figure 58. Sales Channel: Direct Channel vs Indirect Channel